| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Warmuth Markus is a President &CEO at Monte Rosa Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $11.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | GLUE Monte Rosa Therapeutics, Inc. | President &CEO | Sell | 5,467 | $18.92 | $103,446.57 | -0.9% | - | - | |
| Jan 7, 2026 | GLUE Monte Rosa Therapeutics, Inc. | President &CEO | Sell | 5,466 | $23.49 | $128,372.57 | -0.3% | -26.5% | - | |
| Jan 5, 2026 | GLUE Monte Rosa Therapeutics, Inc. | President &CEO | Sell | 10,135 | $15.17 | $153,747.95 | -1.6% | +17.6% | - |